Medpace Holdings Inc (MEDP)
407.15
+30.89
(+8.21%)
USD |
NASDAQ |
Apr 23, 16:00
415.00
+7.85
(+1.93%)
After-Hours: 04:22
Medpace Holdings Shareholders Equity (Quarterly): 558.95M for Dec. 31, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 558.95M |
| September 30, 2023 | 470.91M |
| June 30, 2023 | 391.06M |
| March 31, 2023 | 347.26M |
| December 31, 2022 | 386.39M |
| September 30, 2022 | 349.88M |
| June 30, 2022 | 283.25M |
| March 31, 2022 | 605.02M |
| December 31, 2021 | 952.93M |
| September 30, 2021 | 898.08M |
| June 30, 2021 | 851.88M |
| March 31, 2021 | 858.93M |
| December 31, 2020 | 805.78M |
| September 30, 2020 | 791.63M |
| June 30, 2020 | 738.07M |
| March 31, 2020 | 717.80M |
| December 31, 2019 | 726.28M |
| Date | Value |
|---|---|
| September 30, 2019 | 692.01M |
| June 30, 2019 | 658.06M |
| March 31, 2019 | 621.90M |
| December 31, 2018 | 589.70M |
| September 30, 2018 | 561.39M |
| June 30, 2018 | 540.08M |
| March 31, 2018 | 511.07M |
| December 31, 2017 | 503.53M |
| September 30, 2017 | 550.25M |
| June 30, 2017 | 607.36M |
| March 31, 2017 | 620.98M |
| December 31, 2016 | 610.71M |
| September 30, 2016 | 610.54M |
| June 30, 2016 | 422.64M |
| March 31, 2016 | 417.86M |
| December 31, 2015 | 413.47M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
283.25M
Minimum
Jun 2022
952.93M
Maximum
Dec 2021
636.01M
Average
692.01M
Median
Sep 2019
Shareholders Equity (Quarterly) Benchmarks
| Charles River Laboratories International Inc | 3.597B |
| Avid Bioservices Inc | 183.68M |
| Iovance Biotherapeutics Inc | 584.61M |
| Renovaro Inc | 43.60M |
| Candel Therapeutics Inc | 12.74M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.657B |
| Total Liabilities (Quarterly) | 1.098B |
| Current Ratio | 0.6419 |
| Net Debt Paydown Yield | 0.30% |